Interests: exercise in AF (NEXAF Trial), cardiovascular physiology, sports cardiology (and mostly everything cardiology)
See for example how indexing the LV to BSA does not differentiate these samples at all⬇️8/n
See for example how indexing the LV to BSA does not differentiate these samples at all⬇️8/n
https://academic.oup.com/ejcts/article/64/5/ezad322/7277202
No sign association to PA, but a trend of ⬆️risk of AVR in the most physically active. Several possible...
https://academic.oup.com/ejcts/article/64/5/ezad322/7277202
No sign association to PA, but a trend of ⬆️risk of AVR in the most physically active. Several possible...
Congrats to dear colleagues, and especially @john_nyb 👏🏻 https://www.jacc.org/doi/10.1016/j.jcmg.2023.08.011
Congrats to dear colleagues, and especially @john_nyb 👏🏻 https://www.jacc.org/doi/10.1016/j.jcmg.2023.08.011
As the fig shows; considerable overlap for LVEDV/BSA but discrimination for LVEDV/VO2peak.
As the fig shows; considerable overlap for LVEDV/BSA but discrimination for LVEDV/VO2peak.
In our latest paper we show how LVEDV/VO2peak discriminates LV enlargement in heart failure from physiological enlargement in athletes. New index for heart failure diagnostics? ⬇️🧵#cardiotwitter
In our latest paper we show how LVEDV/VO2peak discriminates LV enlargement in heart failure from physiological enlargement in athletes. New index for heart failure diagnostics? ⬇️🧵#cardiotwitter
Well done and congrats to colleague Torfinn Eriksen-Volnes with the first paper of his PhD!
Well done and congrats to colleague Torfinn Eriksen-Volnes with the first paper of his PhD!
➡️larger upper normal limits for RV dimensions and LA max volumes than prior studies #OpenAccess...
➡️larger upper normal limits for RV dimensions and LA max volumes than prior studies #OpenAccess...
🏃🏼♀️HIIT ⬇️ atheroma volume #ESCCongress
🏃🏼♀️HIIT ⬇️ atheroma volume #ESCCongress
(Okei da, sleng innom siste fem da, @almightygod! Står tross alt om VM her!)
(Okei da, sleng innom siste fem da, @almightygod! Står tross alt om VM her!)